Biennial Analysis of Medication Guide Length and Estimated Readability for New Molecular Entity Drugs, 2011β2017 is a research paper published in Therapeutic Innovation & Regulatory Science (2021). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
Intramural FDA HHS
Grant: FD999999
FWCI
0.00
Citation Percentile
0.1%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals